Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers

Authors: Hoffmann, Udo, Lu, Michael T., Olalere, Devvora, Adami, Elizabeth C., Osborne, Michael T., Ivanov, Alex, Aluru, John Sukumar, Lee, Saeyun, Arifovic, Nadja, Overton, Edgar Turner, Fichtenbaum, Carl J., Aberg, Judith A., Alston-Smith, Beverly, Klingman, Karin L., Waclawiw, Myron, Burdo, Tricia H., Williams, Kenneth C., Zanni, Markella V., Desvigne-Nickens, Patrice, Cooper-Arnold, Katharine, Fitch, Kathleen V., Ribaudo, Heather, Douglas, Pamela S., Grinspoon, Steven K.

Source: In American Heart Journal June 2019 212:1-12

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

Authors: Grinspoon, Steven K., Fitch, Kathleen V., Overton, Edgar Turner, Fichtenbaum, Carl J., Zanni, Markella V., Aberg, Judith A., Malvestutto, Carlos, Lu, Michael T., Currier, Judith S., Sponseller, Craig A., Waclawiw, Myron, Alston-Smith, Beverly, Cooper-Arnold, Katharine, Klingman, Karin L., Desvigne-Nickens, Patrice, Hoffmann, Udo, Ribaudo, Heather J., Douglas, Pamela S.

Source: In American Heart Journal June 2019 212:23-35

Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy

Authors: PROMISE (Promoting Maternal and Infant Safety Everywhere) 1077HS Team, Hoffman, Risa M., Brummel, Sean S., Britto, Paula, Pilotto, Jose H., Masheto, Gaerolwe, Aurpibul, Linda, Joao, Esau, Purswani, Murli U., Buschur, Shelley, Pierre, Marie Flore, Coletti, Anne, Chakhtoura, Nahida, Klingman, Karin L., Currier, Judith S.

Source: Clinical Infectious Diseases, 2019 Jan . 68(2), 273-279.

Access URL: https://www.jstor.org/stable/26574005

Risk of Suicidal Behavior With Use of Efavirenz : Results from the Strategic Timing of Antiretroviral Treatment Trial

Authors: INSIGHT START study group, Arenas-Pinto, Alejandro, Grund, Birgit, Sharma, Shweta, Martinez, Esteban, Cummins, Nathan, Fox, Julie, Klingman, Karin L., Sedlacek, Dalibor, Collins, Simon, Flynn, Patricia M., Chasanov, William M., Kedem, Eynat, Katlama, Christine, Sierra-Madero, Juan, Afonso, Claudia, Brouwers, Pim, Cooper, David A.

Source: Clinical Infectious Diseases, 2018 Aug 01. 67(3), 420-429.

Access URL: https://www.jstor.org/stable/26526361

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210

Authors: Johnson, Victoria A., Cramer, Yoninah S., Rosenkranz, Susan L., Becker, Stephen, Klingman, Karin L., Kallungal, Beatrice, Coakley, Eoin, Acosta, Edward P., Calandra, Gary, Saag, Michael S.

Source: AIDS research and human retroviruses. 35(8):691-697

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100086217054.0x000001&indx=1&recIds=ETOCvdc_100086217054.0x000001

The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV.

Authors: Lake, Jordan E., Kitch, Douglas W., Kantor, Amy, Muthupillai, Raja, Klingman, Karin L., Vernon, Christina, Belaunzaran-Zamudio, Pablo F., Fichtenbaum, Carl J., Heath, Sonya, Perazzo, Hugo, Corey, Kathleen, Brown, Todd T., Landay, Alan, Sattler, Fred, Erlandson, Kristine M.

Source: Annals of Internal Medicine; Jun2024, Vol. 177 Issue 6, p835-838, 11p

Subject Terms: FATTY liver, LIVER diseases, HIV-positive persons, HEPATITIS C, SEMAGLUTIDE

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

Authors: O'Connor, Jemma, Vjecha, Michael J, Phillips, Andrew N, Angus, Brian, Cooper, David, Grinsztejn, Beatriz, Lopardo, Gustavo, Das, Satyajit, Wood, Robin, Wilkin, Aimee, Klinker, Hartwig, Kantipong, Pacharee, Klingman, Karin L, Jilich, David, Herieka, Elbushra, Denning, Eileen, Abubakar, Ibrahim, Gordin, Fred, Lundgren, Jens D

Source: In The Lancet HIV March 2017 4(3):e105-e112

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol

Authors: Bergstrom, Katherine, Boone, Linda, Myers, Laurie, Meres, Debra, Shin, Katherine, Aweeka, Francesca, Cavanagh, Karen, Medvik, Kathleen A., Hovind, Laura, Shaw, Karl, Zadzilla, Amanda, Nixon, Daniel E., Bosch, Ronald J., Chan, Ellen S., Funderburg, Nicholas T., Hodder, Sally, Lake, Jordan E., Lederman, Michael M., Klingman, Karin L., Aberg, Judith A.

Source: In Journal of Clinical Lipidology January-February 2017 11(1):61-69

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial

Authors: Hoffman, Risa M., Angelidou, Konstantia Nadia, Brummel, Sean S., Saidi, Friday, Violari, Avy, Dula, Dingase, Mave, Vidya, Fairlie, Lee, Theron, Gerhard, Kamateeka, Moreen, Chipato, Tsungai, Chi, Benjamin H., Stranix-Chibanda, Lynda, Nematadzira, Teacler, Moodley, Dhayendre, Bhattacharya, Debika, Gupta, Amita, Coletti, Anne, McIntyre, James A., Klingman, Karin L., Chakhtoura, Nahida, Shapiro, David E., Fowler, Mary Glenn, Currier, Judith S.

Source: HIV clinical trials. 19(6):209-224

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100078191030.0x000001&indx=1&recIds=ETOCvdc_100078191030.0x000001

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

Authors: Gulick, Roy M., Wilkin, Timothy J., Chen, Ying Q., Landovitz, Raphael J., Amico, K. Rivet, Young, Alicia M., Richardson, Paul, Marzinke, Mark A., Hendrix, Craig W., Eshleman, Susan H., McGowan, Ian, Cottle, Leslie M., Andrade, Adriana, Marcus, Cheryl, Klingman, Karin L., Chege, Wairimu, Rinehart, Alex R., Rooney, James F., Andrew, Philip, Salata, Robert A., Magnus, Manya, Farley, Jason E., Liu, Albert, Frank, Ian, Ho, Ken, Santana, Jorge, Stekler, Joanne D., McCauley, Marybeth, Mayer, Kenneth H.

Source: The Journal of Infectious Diseases, 2017 Jan . 215(2), 238-246.

Access URL: https://www.jstor.org/stable/26166645

A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy

Authors: Presti, Rachel M, Yeh, Eunice, Williams, Brett, Landay, Alan, Jacobson, Jeffrey M, Wilson, Cara, Fichtenbaum, Carl J, Utay, Netanya S, Dube, Michael P, Klingman, Karin L, Estes, Jacob D, Flynn, Jacob K, Loftin, Amanda, Brenchley, Jason M, Andrade, Adriana, Kitch, Douglas W, Overton, Edgar T

Source: Open forum infectious diseases. 8(12)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138612020.0x000001&indx=1&recIds=ETOCvdc_100138612020.0x000001

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

Authors: AIDS Clinical Trials Group A5303 Study Team, Taiwo, Babafemi O., Chan, Ellen S., Fichtenbaum, Carl J., Ribaudo, Heather, Tsibris, Athe, Klingman, Karin L., Eron, Joseph J., Berzins, Baiba, Robertson, Kevin, Landay, Alan, Ofotokun, Igho, Brown, Todd

Source: Clinical Infectious Diseases, 2015 Oct 01. 61(7), 1179-1188.

Access URL: https://www.jstor.org/stable/26368634

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230

Authors: Kumarasamy, Nagalingeswaran, Aga, Evgenia, Ribaudo, Heather J., Wallis, Carole L., Katzenstein, David A., Stevens, Wendy S., Norton, Michael R., Klingman, Karin L., Hosseinipour, Mina C., Crump, John A., Supparatpinyo, Khuanchai, Badal-Faesen, Sharlaa, Bartlett, John A.

Source: Clinical Infectious Diseases, 2015 May . 60(10), 1552-1558.

Access URL: https://www.jstor.org/stable/26366625

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)

Authors: Nixon, Daniel E., Bosch, Ronald J., Chan, Ellen S., Funderburg, Nicholas T., Hodder, Sally, Lake, Jordan E., Lederman, Michael M., Klingman, Karin L., Aberg, Judith A.

Source: Journal of clinical lipidology. 11(1):61-69

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100052369395.0x000001&indx=1&recIds=ETOCvdc_100052369395.0x000001

Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir

Authors: Chan, Ellen S., Landay, Alan L., Brown, Todd T., Ribaudo, Heather J., Mirmonsef, Paria, Ofotokun, Igho, Weitzmann, M. Neale, Martinson, Jeffrey, Klingman, Karin L., Eron, Joseph J., Fichtenbaum, Carl J., Plants, Jill, Taiwo, Babafemi O.

Source: AIDS. 30(13):2091-2097

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100034168247.0x000001&indx=1&recIds=ETOCvdc_100034168247.0x000001

Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV

Authors: McMahon, Deborah K., Zheng, Lu, Hitti, Jane, Chan, Ellen S., Halvas, Elias K., Hong, Feiyu, Kabanda, Joseph, Taulo, Frank, Kumarasamy, Nagalingeswaran, Bonhomme, Jerry, Wallis, Carole L., Klingman, Karin L., Hughes, Michael D., Mellors, John W.

Source: Clinical Infectious Diseases, 2013 Apr 01. 56(7), 1044-1051.

Access URL: http://dx.doi.org/10.1093/cid/cis1219

Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race — ethnicity determine the degree of regimen complexity

Authors: Tashima, Karen T., Mollan, Katie R., Na, Lumine, Gandhi, Rajesh T., Klingman, Karin L., Fichtenbaum, Carl J., Andrade, Adriana, Johnson, Victoria A., Eron, Joseph J., Smeaton, Laura

Source: HIV clinical trials. 16(4):147-156

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN602264413&indx=1&recIds=ETOCRN602264413

Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving Either Triple-Nucleoside or Efavirenz-Containing Regimens: ACTG A5166s

Authors: ACTG A5166s Protocol Team, Kuritzkes, Daniel R., Ribaudo, Heather J., Squires, Kathleen E., Koletar, Susan L., Santana, Jorge, Riddler, Sharon A., Reichman, Richard, Shikuma, Cecilia, Meyer, William A., Klingman, Karin L., Gulick, Roy M.

Source: The Journal of Infectious Diseases, 2007 Apr . 195(8), 1169-1176.

Access URL: https://www.jstor.org/stable/30087352

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Authors: Fowler, Mary G., Qin, Min, Fiscus, Susan A., Currier, Judith S., Flynn, Patricia M., Chipato, Tsungai, McIntyre, James, Gnanashanmugam, Devasena, Siberry, George K., Coletti, Anne S., Taha, Taha E., Klingman, Karin L., Martinson, Francis E., Owor, Maxensia, Violari, Avy, Moodley, Dhayendre, Theron, Gerhard B., Bhosale, Ramesh, Bobat, Raziya, Chi, Benjamin H., Strehlau, Renate, Mlay, Pendo, Loftis, Amy J., Browning, Renee, Fenton, Terence, Purdue, Lynette, Basar, Michael, Shapiro, David E., Mofenson, Lynne M.

Source: Obstetrical & gynecological survey. 72(3):143-145

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100042411914.0x000001&indx=1&recIds=ETOCvdc_100042411914.0x000001

Simultaneous Respiratory Tract Colonization by Multiple Strains of Nontypeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease: Implications for Antibiotic Therapy

Authors: Murphy, Timothy F., Sethi, Sanjay, Klingman, Karin L., Brueggemann, Angela B., Doern, Gary V.

Source: The Journal of Infectious Diseases, 1999 Aug 01. 180(2), 404-409.

Access URL: https://www.jstor.org/stable/30111025